161 related articles for article (PubMed ID: 19968026)
21. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.
Deitelzweig SB; Becker R; Lin J; Benner J
Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525
[TBL] [Abstract][Full Text] [Related]
22. How do we manage venous thromboembolism in pregnancy? A retrospective review of the practice of diagnosing and managing pregnancy-related venous thromboembolism at two major hospitals in Australia and New Zealand.
Chan N; Merriman E; Hyder S; Woulfe T; Tran H; Chunilal S
Intern Med J; 2012 Oct; 42(10):1104-12. PubMed ID: 22755545
[TBL] [Abstract][Full Text] [Related]
23. [Place of cancer among the risk factors in venous thromboembolism].
Descourt R; Righini M; Carrier M; Le Gal G
Pathol Biol (Paris); 2008 Jun; 56(4):178-83. PubMed ID: 18325691
[TBL] [Abstract][Full Text] [Related]
24. Treatment of venous thromboembolism in cancer patients.
Lee AY
Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276
[TBL] [Abstract][Full Text] [Related]
25. The link between cancer and venous thromboembolism: a review.
Kessler CM
Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S3-7. PubMed ID: 19654481
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
Peterman CM; Kolansky DM; Spinler SA
Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolic disease in autogenous breast reconstruction.
Pannucci CJ; Chang EY; Wilkins EG
Ann Plast Surg; 2009 Jul; 63(1):34-8. PubMed ID: 19546669
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism and pancreatic cancer: incidence, pathogenesis and clinical implications.
Mandalà M; Moro C; Labianca R
Onkologie; 2008 Mar; 31(3):129-35. PubMed ID: 18322417
[TBL] [Abstract][Full Text] [Related]
29. Key articles and guidelines for the prevention of venous thromboembolism.
Dobesh PP; Wittkowsky AK; Stacy Z; Dager WE; Haines ST; Lopez LM; Nutescu E; Phillips KW; Trujillo TC; Vondracek T
Pharmacotherapy; 2009 Apr; 29(4):410-58. PubMed ID: 19323620
[TBL] [Abstract][Full Text] [Related]
30. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice.
Otero-Fernández R; Gómez-Outes A; Martínez-González J; Rocha E; Fontcuberta J;
Clin Appl Thromb Hemost; 2008 Jan; 14(1):75-83. PubMed ID: 17895506
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism in acutely ill hospitalized medical patients.
Barba R; Zapatero A; Losa JE; Marco J; Plaza S; Canora J; Casas JM
Thromb Res; 2010 Oct; 126(4):276-9. PubMed ID: 20659763
[TBL] [Abstract][Full Text] [Related]
33. [Venous thromboembolism in intensive care unit patients].
Habeşoğlu MA; Oner Eyüboğlu F
Tuberk Toraks; 2010; 58(3):321-33. PubMed ID: 21038146
[TBL] [Abstract][Full Text] [Related]
34. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
35. Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery. Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL).
Kalka C; Spirk D; Siebenrock KA; Metzger U; Tuor P; Sterzing D; Oehy K; Wondberg D; Mouhsine el Y; Gautier E; Kucher N
Thromb Haemost; 2009 Jul; 102(1):56-61. PubMed ID: 19572068
[TBL] [Abstract][Full Text] [Related]
36. Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort.
Leibson CL; Needleman J; Buerhaus P; Heit JA; Melton LJ; Naessens JM; Bailey KR; Petterson TM; Ransom JE; Harris MR
Med Care; 2008 Feb; 46(2):127-32. PubMed ID: 18219240
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
[TBL] [Abstract][Full Text] [Related]
38. Guidelines for venous thromboembolism and clinical practice in Italy: a nationwide survey.
de Franciscis S; Agus GB; Bisacci R; Botta G; Gasbarro V; Domanin M; Nobile CG; Serra R
Ann Vasc Surg; 2008; 22(3):319-27. PubMed ID: 18466813
[TBL] [Abstract][Full Text] [Related]
39. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
40. Approaches to risk-stratifying cancer patients for venous thromboembolism.
Khorana AA; Rao MV
Thromb Res; 2007; 120 Suppl 2():S41-50. PubMed ID: 18023712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
